DUBLIN–(BUSINESS WIRE)–Jan 29, 2021–
The "Protein A Resin Market by Product (Agarose-based, Glass/Silica-based), Type (Recombinant Protein A, Natural Protein A), Application (Antibody Purification, Immunoprecipitation), & End User – Global Forecast to 2025" report has been added to ResearchAndMarkets.com’s offering.
The global protein A resin market is projected to reach USD 1,916.3 million by 2025 from an estimated USD 1,115.8 million in 2020, at a CAGR of 11.4% during the forecast period.
The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide.
Growth in the market can primarily be attributed to factors such as demand for pre-packed disposable columns, increasing demand for therapeutic antibodies, and increasing pharmaceutical R&D spending
The agarose-based protein A segment to hold the largest market share in 2020.
Based on product, the protein A resin market is segmented into agarose-based protein A, glass/silica-based protein A, and organic polymer-based protein A. In 2020, the agarose-based protein A segment is expected to command the largest share of the protein A resin market. The large share of this segment can be attributed to the agarose being the most widely used matrix resin for the attachment of ligands that bind proteins.
The recombinant protein A segment to hold the largest market share in 2020.
Based on type, the protein A resin market is segmented into recombinant protein A and natural protein. In 2020, the recombinant protein A segment is expected to command the largest share of the protein A resin market. The large share of this segment can be attributed to the frequent use of recombinant protein A resins during the production of monoclonal antibodies.
The pharmaceutical and biopharmaceutical companies segment to hold the largest market share in 2020.
Based on end user, the protein A resin market is segmented into pharmaceutical & biopharmaceutical companies, academic research institutes, and other end users. In 2020, the pharmaceutical and biopharmaceutical companies segment is expected to command the largest share of the protein A resin market. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the major factor driving the growth of this end-user segment.
The Asia Pacific region to witness the highest growth during the forecast period.
Geographically, North America dominated the global protein A resin market in 2020. However, the Asia Pacific market is expected to register the highest during the forecast period. The major factors driving the growth of the Asia Pacific market include increased R&D activities, as APAC has emerged as a key pharmaceutical and biopharmaceutical research hub. Considering this, a number of key pharmaceutical and biopharmaceutical companies have set up their research centers in the region. Also, local major players such as Ranbaxy, Dr. Reddy’s, Cipla, Lupin, and Cadila are actively involved in research on biosimilars and generic drugs.
Market Dynamics
Drivers
- Growing Demand for Disposable Pre-Packed Columns
- Increasing Demand for Therapeutic Antibodies
- Increasing Pharmaceutical R&D Spending
Restraints
- High Cost of Resins
- Dearth of Skilled Professionals
Opportunities
- Increasing Number of Cmos and Cros
- Increasing Demand for Biosimilars
Companies Mentioned
- Abcam plc.
- Agarose Bead Technologies
- Agilent Technologies, Inc.
- Aneka Corporation
- Avantor, Inc.
- Bio-Rad Laboratories, Inc.
- Bio-Works Technologies
- GE Healthcare
- Generon
- Genscript Biotech Corporation
- JSR Life Sciences
- Merck Millipore
- Novasep Holding Sas
- Orochem
- Perkinelmer, Inc.
- Purolite Corporation
- Repligen Corporation
- Takara Bio
- Thermo Fisher Scientific, Inc.
- Tosoh Bioscience
For more information about this report visit https://www.researchandmarkets.com/r/25egon
View source version on businesswire.com:https://www.businesswire.com/news/home/20210129005298/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 01/29/2021 08:03 AM/DISC: 01/29/2021 08:03 AM
http://www.businesswire.com/news/home/20210129005298/en
